Trial Profile
Randomized,Double-blind Trial Comparing the Effects of a Rivaroxaban Regimen During the First 30 Days,Versus Aspirin for the Acute Treatment of TIA or Minor Stroke
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Aspirin
- Indications Stroke; Transient ischaemic attacks; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms TRACE
- 19 Aug 2013 New trial record